Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00136929
Status:
UNKNOWN
Last Update Posted:
2005-12-13
First Post:
2005-08-26
Brief Title:
Senior PAMI Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly
Sponsor:
PAMI Coordinating Center
Organization:
PAMI Coordinating Center
Study Overview
Official Title:
A Prospective Randomized Trial of Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly Senior PAMI
Status:
UNKNOWN
Status Verified Date:
2005-08
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective randomized multi-center international trial comparing two reperfusion strategies in elderly age 70 years patients with acute myocardial infarction primary percutaneous coronary intervention PCI versus intravenous thrombolytic therapy Clinical endpoints will be collected in the hospital at 1 month 6 months and 1 year post-randomization The primary endpoint is 30 day death or disabling stroke The study null hypothesis is that there will be no significant difference in death or disabling stroke at 30 days post-randomization between patients treated with PCI versus thrombolytics
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None